Preclinical findings demonstrate that panaxynol improves colonic microenvironment and reduces injury in mice during chemotherapy, indicating its potential as treatment.
abundance was primarily influenced by 5FU treatment. These preclinical findings support the potential of panaxynol as a therapeutic candidate for the treatment of CIM and highlight the importance of considering sex as a biological variable.
No takes yet. Share an insight, caveat, or question.
Bullard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: